Financials

  • Market Capitalization 4.8642 B
  • Employee 362
  • Founded 2018
  • CEO N/A
  • Website www.immunovant.com
  • Headquarter Delaware, United States
  • FIGI BBG00P5MC0Q8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.26
Price to sales ratio
Dividends per share
Dividend yield %

Nachrichten